Press Release Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update Allogene Therapeutics, Inc. · Aug 12
Press Release Global Crossing Airlines Reports Second Quarter 2026 Financial Results Global Crossing Airlines Group Inc. · Aug 12
Press Release Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update Longeveron · Aug 12
Press Release Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million Royalty Pharma plc · Aug 12
Press Release OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance OptimizeRx Corporation · Aug 12
Press Release Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update Spero Therapeutics, Inc. · Aug 12
Press Release Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update Connect Biopharma Holdings Limited · Aug 12
Press Release AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for August 2026 AGNC Investment Corp. · Aug 12
Press Release Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update Talphera, Inc. · Aug 12